Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Tethis S.p.A logo — company profile

Tethis S.p.A

Founded 2004 Italy Italy 31 employees Grant Total: $71.43K Biotechnology

General Information

Company Name Tethis S.p.A
Founded Year 2004
Location Italy Italy +1
Founders / Decision Makers
Team member Team member
Employees 31
Industries Biotechnology
Funding Stage Grant
Social

Get notified when Tethis S.p.A moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Tethis S.p.A

Tethis S.p.A is a biotechnology startup based in Italy that was founded in 2004. The company aims to revolutionize oncology diagnostics by making liquid biopsy a standard, reproducible practice. Their proprietary slides enable immediate, fully automated, and gentle processing of blood samples, addressing crucial unmet needs for standardization and maintaining clinical informativity. Tethis focuses on conducting high throughput analytical protocols for highly sensitive and specific blood-based cancer testing in various clinical settings. Their most recent investment was a €71.43K Grant investment received on 01 May 2018, with the details of the investors undisclosed at this time. Tethis's innovative approach to liquid biopsy and cancer testing presents a compelling proposition for potential investors in the biotechnology sector.

Taxonomy: liquid biopsy, oncology diagnostic, proprietary slides, blood samples processing, clinical informativity, high throughput analytical protocols, cancer testing, clinical settings

Funding Rounds & Investors (6)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• - 01 May 2018
Venture Round •••••• 1 •••• •••• 28 Feb 2014
Venture Round •••••• 1 •••• •••• 28 Feb 2013
Venture Round •••••• 1 •••• •••• 28 Sep 2012
Venture Round •••••• 1 •••• •••• 15 Feb 2012

View All 6 Funding Rounds

Tethis S.p.A Alternatives & Competitors

Tethis S.p.A vs
Salmedix
Salmedix

Pioneering advanced treatments for blood cancers, delivering innovative Phase II clinical trials wit...

Series C
Biotechnology, Health Care
Compare Tethis S.p.A vs Salmedix
Tethis S.p.A vs
Cure Leukaemia
Cure Leukaemia United Kingdom

We fund the Trials Acceleration Programme (TAP) which delivers & connects patients to blood cancer c...

23 employees
Health Care
Compare Tethis S.p.A vs Cure Leukaemia
Tethis S.p.A vs
IPSA S.r.l.
IPSA S.r.l. Italy

Smart Solutions for Healthcare

28 employees
Health Care, IT
Compare Tethis S.p.A vs IPSA S.r.l.

FAQ About Tethis S.p.A

At Tethis we aim to make liquid biopsy a standard, reproducible, oncology diagnostic. Our proprietary slides allow immediate, fully automated and gentle processing of blood samples, three unaddressed elements that are crucial to ensure standardization and to maintain clinical informativity. High thr...
Tethis S.p.A was founded in 2004.
Tethis S.p.A is headquartered in Italy.
Tethis S.p.A operates in the following industries: Biotechnology.
Tethis S.p.A has approximately 31 employees.
Tethis S.p.A has completed 6 funding rounds, raising a total of $71.43K. The latest funding stage is Grant.
Top alternatives and competitors to Tethis S.p.A include Salmedix, Cure Leukaemia, IPSA S.r.l., Hemostemix Inc., Alertive Healthcare. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Tethis S.p.A and Salmedix are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Tethis S.p.A and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy